来自:中国糖尿病杂志 编辑:金月萍 苏晓飞|点击数:|2015-06-16
讲座
【摘要】 LADA属于T1DM,其早期表现类似T2DM。LADA在新诊断T2DM患者中发病率为10%。国内外公认的LADA诊断要点为成年起病、存在胰岛自身抗体和诊断后至少6个月不依赖胰岛素治疗。其中,胰岛自身抗体是诊断LADA的重要指标。基因、非胰岛细胞的自身抗体和细胞免疫标志可能成为新的辅助诊断依据。早期应用胰岛素可能对部分LADA患者胰岛细胞有保护作用。
【关键词】成人隐匿性自身免疫性糖尿病;诊断;治疗
【Summary】LADA presenting with a similar phenotype of T2DM at early stage, belongs to the slowly progressive subtype of autoimmune T1DM. The proportion of LADA in newly diagnosed T2DM is about 10%. Recognized LADA diagnosis points mainly include: adult onset, autoantibody of islets, and no relying on insulin therapy at least six months after diagnosis. Therein, autoantibody of islets is important index in diagnosing LADA. Genes, other autoantibodies and cellular immune markers are expected to become the new diagnosis basis. For some LADA patients, treatment with insulin earlier may have protective effect on islet cell function.
【Key words】Latent autoimmune diabetes in adult (LADA);Diagnosis;Therapy
版权所有:《中国糖尿病杂志》社 主管单位:中华人民共和国教育部 主办单位:北京大学
地址:北京市西城区大红罗厂街1号 邮编:100034 电话(传真):010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持:九度创想